Navigation Links
Boston Scientific Begins Clinical Trial for Next-Generation Nitinol Stent to Treat Iliac Artery Disease
Date:5/20/2009

25 sites in the U.S. and will examine rates of device- and/or procedure-related major adverse events (MAE) at nine months. MAE are currently defined as death within 30 days, myocardial infarction (MI, or heart attack) occurring during related hospitalization, target vessel revascularization (TVR) through nine months and amputation of the treated limb through nine months.

The EPIC Stent is a next-generation product that builds on Boston Scientific's long-time leadership in the peripheral interventions market. The Company's peripheral product lines feature technologies used to diagnose and treat peripheral disease, including stents, balloon catheters, sheaths, wires, peripheral embolization solutions and vena cava filters. This advanced product portfolio offers physicians a range of peripheral stent indications, including the Carotid Wallstent(R) Endoprosthesis for carotid artery disease and the Express(R) SD Stent for renal artery disease.

The EPIC Nitinol Stent System is an investigational device and is limited by applicable law to investigational use only and is not available for sale in the U.S.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent
2. Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials
3. Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientifics TAXUS(R) Liberte(R) Stent
4. Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine
5. Clinical Data Reinforce Safety and Efficacy of Boston Scientifics Two Drug- Eluting Stent Platforms
6. New England Journal of Medicine Publishes Results from Boston Scientifics Landmark SYNTAX(TM) Trial
7. Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
8. Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent
9. Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientifics Next-Generation Taxus Liberte Stent
10. Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008
11. Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 20, 2013  TRACE International today released its ... that prosecutions against individuals and government or business entities ... GER 2012 is the third in an ... trends. "Although the number of outbound enforcement ... remained a priority," said Alexandra Wrage ...
(Date:5/20/2013)... NEW YORK , May 20, 2013  Echo ... Rule 2.5 of the Irish Takeover Rules (the "Announcement"), ... Corporation, plc (NYSE: ELN ) to $12.50 ... financed, cash confirmed and not conditional on due diligence.  ... eliminated.  Royalty Pharma has reserved the right to waive ...
(Date:5/20/2013)... , May 20, 2013 A medical ... use both in space and on Earth was inducted ... The technology assures high quality, secure handling ... low-power ultrasound units, like those used in hospitals and ... the diagnostic imaging solution of choice for human space ...
Breaking Medicine Technology:TRACE Releases 2012 Global Enforcement Report 2TRACE Releases 2012 Global Enforcement Report 3Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 2Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 3Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 4Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 5Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 6Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 7Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 8Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 9Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 10Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 11Wyle Aided System Gets Named to Space Technology Hall of Fame 2Wyle Aided System Gets Named to Space Technology Hall of Fame 3
... July 27, 2011 HeartWare International, Inc. (NASDAQ: HTWR, ASX:HIN) ... six months ended June 30, 2011, after the close of ... A conference call with management is scheduled for 5:00 ... (being 7:00 am Australian Eastern Standard Time, Friday, August 5, ...
... July 27, 2011 Stryker Neurovascular, a division of ... and Platinum Science (MAPS) Trial during the Society of ... The MAPS Trial establishes a new standard for the ... (TAR)*, and proves that coiling is an excellent treatment ...
Cached Medicine Technology:HeartWare to Report Financial Results for Second Quarter of 2011 2Landmark Stryker Trial Establishes Coiling as Safe and Effective Treatment for Ruptured and Unruptured Aneurysms 2Landmark Stryker Trial Establishes Coiling as Safe and Effective Treatment for Ruptured and Unruptured Aneurysms 3
(Date:5/20/2013)... 20, 2013 Gilman Law LLP, a ... investigating Byetta lawsuits, is troubled by a new study ... and similar type 2 diabetes drugs are growing. ... Practices (ISMP), found that 71 Byetta pancreatic cancer reports ... Administration (FDA) as of June 30, 2012. ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Headquartered in ... Levy Phillips & Konigsberg LLP (“LPK”) has ... White Plains, New York. LPK will better serve people ... Hudson Valley, including Westchester, Putnam, Rockland, Orange, and Dutchess ... affected by asbestos-related diseases throughout New York, New Jersey, ...
(Date:5/20/2013)... Online education provides the convenience, ... does not offer. According to the American Heart ... switching classroom learning to eLearning due to changing ... helped maximize training budgets, but it is also ... by 25–60%. A higher retention of content is ...
(Date:5/20/2013)... comprised over 24,000 Finnish subjects and was led ... a panel of 28 genetic markers improved detection ... disease (CHD) (10-year risk ≥20%) over traditional risk ... important preventive strategy for CHD, because the current ... "The results indicate that genetic markers could be ...
(Date:5/20/2013)... when a particular strain of avian influenza might become ... to be published in the International Journal Data ... University of Arizona, Tucson, and colleagues at the Huazhong ... Institute of Virology, explain that since 1997 several strains ... "bird flu" have infected people directly from their natural ...
Breaking Medicine News(10 mins):Health News:Byetta Lawyers at Gilman Law, a Leading Pharmacy Law and Defective Drug Plaintiffs’ Law Firm, Troubled by Growing Byetta Pancreatic Cancer Reports 2Health News:Byetta Lawyers at Gilman Law, a Leading Pharmacy Law and Defective Drug Plaintiffs’ Law Firm, Troubled by Growing Byetta Pancreatic Cancer Reports 3Health News:Westchester Mesothelioma Lawyers Open Office in White Plains, New York 2Health News:Westchester Mesothelioma Lawyers Open Office in White Plains, New York 3Health News:Swank HealthCare Announces New Offering of Additional American Heart Association’s Accredited Online Courses 2Health News:Predicting infectious influenza 2
... TV Ad Rebrands California Republican Party as the ,Yacht Party, for ... Supporting ,Yacht Tax, ... Courage Campaign have released a new ad branding the California,Republican Party ... that allows buyers of yachts and private jets to avoid paying,sales ...
... sellout for Actifirm(R), a,leading manufacturer of science-based skin ... on QVC Saturday, May 10., QVC program ... six Actifirm products, including 10% Z-Peel(R); Face Firm(TM);,Renovation ... discovery kit with Actifirm products for cleansing, exfoliating,and ...
... CMS Regulatory Action a,Serious Public Policy Misstep; Seniors, Nursing ... OH, IL, PA, NJ, MI, MA, WASHINGTON, May ... the Bush Administration,s $770 million cut to,Medicare-financed nursing home ... regulatory-driven cuts not only jeopardize seniors,access to quality nursing ...
... children exposed to tobacco smoke respond particularly well ... Jewish Medical and Research Center. Associate Professor ... also identified two biomarkers that may help physicians ... from montelukast. , These findings will help doctors ...
... - Significant Increase by 31,6% in Sales and 10,3 % in Net ... 31,6% of the Consolidated Sales to EUR 11,3m in the First ... - Increased by 12,7% of the Consolidated EBITDA to EUR 2,6m (from ... Net Profits (EAT) Increased by 10,3% to EUR 1,5m (from EUR 1,4m in ...
... Pepper Award nominations, DETROIT, May 13 ... lives of Michigan,s senior citizens have until June ... Shield of Michigan,s Claude,Pepper Award., The award ... volunteer efforts have made significant contributions to improving ...
Cached Medicine News:Health News:California Nurses Association, Courage Campaign, Arianna Huffington Team up for 'Yacht Party 2' TV Ad 2Health News:California Nurses Association, Courage Campaign, Arianna Huffington Team up for 'Yacht Party 2' TV Ad 3Health News:Actifirm Sells Out in First Hour Appearance on QVC 2Health News:New Studies of Bush Administration $770 Million SNF Medicare Cut Find Seniors' Care Jeopardized, Local Jobs Lost, National and State Economies Threatened 2Health News:New Studies of Bush Administration $770 Million SNF Medicare Cut Find Seniors' Care Jeopardized, Local Jobs Lost, National and State Economies Threatened 3Health News:New Studies of Bush Administration $770 Million SNF Medicare Cut Find Seniors' Care Jeopardized, Local Jobs Lost, National and State Economies Threatened 4Health News:Girls and children exposed to tobacco smoke benefit more from montelukast (singulair) 2Health News:KORRES Q1 2008 Results 2Health News:Blue Cross Blue Shield of Michigan Seeking Nominations for Outstanding Senior Advocates 2
... TM-1 is a compact multi-functional ... precise measurement of UVA, UVB, ... all types of lens materials. ... connect with a personal computer ...
... This sleek, contoured instrument table ... room dcor, while providing a sturdy, ... wheelchair compatible design provides completely open ... make positioning quick and easy. The ...
If youre looking to expand your projection capabilities, without a major capital investment, consider Topcons CP-5D Chart Projector....
... corrected curve trial lenses are ground with the ... refractors and are invaluable in treating low vision ... manufacturers contain a disproportionately large number of lenses ... to produce, and fewer lenses in the higher ...
Medicine Products: